Skip to main content

Table 1 Measures of cardiac function in rats with myocardial infarction who received treatment with endothelial progenitor cells

From: Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models

Time Groups EDD ESD FS EF
Week 2 Control (n = 28) 7.01 ± 0.27 4.11 ± 0.17 46.41 ± 2.25 31.67 ± 2.94
  EPCs (n = 28) 6.01 ± 0.19* 3.09 ± 0.18* 60.51 ± 2.17* 66.18 ± 2.16*
Week 4 Control (n = 28) 6.57 ± 0.28 3.66 ± 0.34 43.49 ± 3.07 35.37 ± 2.39
  EPCs (n = 28) 5.69 ± 0.24* 2.64 ± 0.33* 56.48 ± 2.68* 68.39 ± 3.89*
  1. EPC, endothelial progenitor cell; EDD, end diastolic dimension; ESD, end systolic dimension; FS, fractional shortening; EF, ejection fraction.
  2. * Indicates a significant difference between the EPC and control group (P < 0.05).